1. Home
  2. NEXA vs TSHA Comparison

NEXA vs TSHA Comparison

Compare NEXA & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEXA
  • TSHA
  • Stock Information
  • Founded
  • NEXA 1956
  • TSHA 2019
  • Country
  • NEXA Luxembourg
  • TSHA United States
  • Employees
  • NEXA N/A
  • TSHA N/A
  • Industry
  • NEXA Metal Mining
  • TSHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEXA Basic Materials
  • TSHA Health Care
  • Exchange
  • NEXA Nasdaq
  • TSHA Nasdaq
  • Market Cap
  • NEXA 646.3M
  • TSHA 728.4M
  • IPO Year
  • NEXA 2017
  • TSHA 2020
  • Fundamental
  • Price
  • NEXA $4.83
  • TSHA $3.36
  • Analyst Decision
  • NEXA Sell
  • TSHA Strong Buy
  • Analyst Count
  • NEXA 3
  • TSHA 7
  • Target Price
  • NEXA $5.17
  • TSHA $8.71
  • AVG Volume (30 Days)
  • NEXA 10.4K
  • TSHA 3.4M
  • Earning Date
  • NEXA 10-30-2025
  • TSHA 08-12-2025
  • Dividend Yield
  • NEXA 2.08%
  • TSHA N/A
  • EPS Growth
  • NEXA N/A
  • TSHA N/A
  • EPS
  • NEXA N/A
  • TSHA N/A
  • Revenue
  • NEXA $2,785,931,000.00
  • TSHA $8,098,000.00
  • Revenue This Year
  • NEXA N/A
  • TSHA N/A
  • Revenue Next Year
  • NEXA $4.41
  • TSHA N/A
  • P/E Ratio
  • NEXA N/A
  • TSHA N/A
  • Revenue Growth
  • NEXA 7.34
  • TSHA N/A
  • 52 Week Low
  • NEXA $4.44
  • TSHA $1.05
  • 52 Week High
  • NEXA $9.61
  • TSHA $3.40
  • Technical
  • Relative Strength Index (RSI)
  • NEXA 46.41
  • TSHA 70.13
  • Support Level
  • NEXA $4.79
  • TSHA $2.79
  • Resistance Level
  • NEXA $4.98
  • TSHA $2.99
  • Average True Range (ATR)
  • NEXA 0.13
  • TSHA 0.16
  • MACD
  • NEXA -0.00
  • TSHA 0.03
  • Stochastic Oscillator
  • NEXA 43.10
  • TSHA 93.71

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: